• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Coherus price target raised at Baird on agreement to sell Udenyca

by December 5, 2024
written by December 5, 2024

On Thursday, Baird maintained an Outperform rating on Coherus Biosciences (NASDAQ: NASDAQ:CHRS) and increased the price target to $6.00 from the previous $4.00.

The adjustment follows the company’s recent transaction with Intas Pharmaceuticals, where Coherus agreed to sell all formulations of Udenyca for a $483 million cash payment upfront, in addition to potential sales milestones that could total up to $75 million.

The sale of Udenyca is set to significantly impact Coherus’s financial standing, as the cash infusion will allow the company to pay off its $230 million convertible note and approximately $50 million in Udenyca royalty obligations. This move is anticipated to alleviate any concerns regarding the company’s balance sheet and provide a more solid financial foundation.

The capital from this deal is earmarked for advancing Coherus’s immuno-oncology (IO) pipeline. The funds are expected to support the company through several upcoming data catalysts over the next few years, signaling a strategic shift in focus towards the development of its IO portfolio.

Baird’s commentary highlighted the management team’s ability to extract significant value from the sale of multiple assets in 2024. This strategic maneuvering is aimed at narrowing the company’s focus on its IO pipeline, which is now backed by a robust cash reserve.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
2025 to be another year of unbalanced growth: BofA
next post
Starmer pledges measurable ‘milestones’ to rebuild Britain after rocky start

You may also like

BASF results down on impairments, restructuring

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • Divided Fed proposes rule to ease capital requirements for big Wall Street banks

      June 26, 2025
    • Women’s Tennis Association extends media rights deal with Tennis Channel through 2032

      June 26, 2025
    • Bumble shares jump 26% as dating company plans to axe 30% of workforce

      June 26, 2025
    • Small-business AI use is lagging, but one firm is channeling Sherlock Holmes and knocking out ‘grunt work’

      June 25, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (534)
    • Stock (6,426)

    Latest News

    • Divided Fed proposes rule to ease capital requirements for big Wall Street banks
    • Women’s Tennis Association extends media rights deal with Tennis Channel through 2032

    Popular News

    • Meta announces 5% cuts in preparation for ‘intense year.’ Read the internal memo.
    • Electronic Arts: BMO downgrades to Market Perform on weak bookings outlook

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy